Vice President, Chief U.S. Regulatory Counsel & Chief Compliance Officer
Job descriptionWhy Sarepta? Why Now? The reputed company of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, central nervous system, and cardiac diseases. In 2023, we launched our reputed company therapy and the first reputed company gene therapy to treat Duchenne. We’re looking for people who
Apply tot his job
Apply To this Job